Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
about
Changes in malaria burden and transmission in sentinel sites after the roll-out of long-lasting insecticidal nets in Papua New GuineaA systematic review of the efficacy of a single dose artemisinin-naphthoquine in treating uncomplicated malariaIntermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialPlasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea.Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivaxIn vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.Sequence conservation in Plasmodium falciparum alpha-helical coiled coil domains proposed for vaccine development.Resistance to therapies for infection by Plasmodium vivaxPlasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.Treatment with coartem (artemether-lumefantrine) in Papua New GuineaExpression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon.Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in Papua New Guinea using an extended ligase detection reaction fluorescent microsphere assay.Novel genotyping tools for investigating transmission dynamics of Plasmodium falciparumPharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.A Large Plasmodium vivax Reservoir and Little Population Structure in the South Pacific.Improving health worker adherence to malaria treatment guidelines in Papua New Guinea: feasibility and acceptability of a text message reminder serviceA new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes.Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New GuineaMalaria case management in Papua New Guinea prior to the introduction of a revised treatment protocolAntimalarial drug susceptibility of Plasmodium vivax in the Republic of KoreaThe usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New GuineaIn vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy.A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance.Spectrophotometric detection of susceptibility to anti-malarial drugs.
P2860
Q26315315-D0C66DA2-1833-4245-AFEA-A1DAB1A06C56Q26786586-1D6C717C-E572-451B-A889-F55C6BDC507AQ28481649-3C0B9E43-CE72-40CF-B940-77F09933DB47Q33344896-9509CD8D-241A-4479-B789-3374BBA46F4CQ33344900-24E01663-08EE-43AA-8E53-79827B519784Q33371043-6A202D17-45D5-466F-A492-B1CD23833030Q33395221-3B5710C0-84F1-4AC6-9C2B-E16B5E89C8AFQ33459259-6FD92AF9-F85D-4054-921E-490318FDE0A9Q33481576-ABB62070-8B95-4379-BFDE-FF25ED1BBF49Q33645352-1232A03D-9895-4190-ABAD-38118B56AA6AQ33749688-C2CD56B0-7D92-4ADA-9E95-D97B9FDA42B9Q34089944-5BBAA1E9-B9A4-4EFC-BC25-647DEF3DCBA6Q34529101-041A846B-8220-4708-82F4-94BA938B1B27Q34736521-6220BF05-583C-417A-BA70-E91989982542Q34737758-671C93FE-8B80-4D20-9CF6-75A9B51460D5Q34792787-EC081303-247B-4E8D-9A09-E459827DDA3AQ35014734-E6813756-B2EA-460A-A435-BDBB81E2406BQ35338795-2C71F52F-E9B7-458A-9736-39E72C20990AQ36144097-22D71BD2-B839-4081-BC63-C5205DDB1E5EQ36232163-D2FCAED8-C4B9-4C50-B6C8-EBD8D848018DQ36240242-50F0B60B-C1DC-4E8D-87DD-51BD9C2F7596Q36649305-1911E028-4A98-478D-A539-0F3C220DA957Q36667032-4C0E64D5-C550-452E-A07A-375AFFFF19CDQ36993444-E103C465-BCAB-4E51-9660-719F91BEC5E5Q37325659-C6461B9E-C155-476A-ACE3-DC875CF77E68Q41944114-E2258CC3-A526-43E3-8CB7-32F813A5D64DQ42237651-AF6CFB52-169C-4F35-A148-B29868480C43
P2860
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Low efficacy of amodiaquine or ...... x malaria in Papua New Guinea.
@en
Low efficacy of amodiaquine or ...... x malaria in Papua New Guinea.
@nl
type
label
Low efficacy of amodiaquine or ...... x malaria in Papua New Guinea.
@en
Low efficacy of amodiaquine or ...... x malaria in Papua New Guinea.
@nl
prefLabel
Low efficacy of amodiaquine or ...... x malaria in Papua New Guinea.
@en
Low efficacy of amodiaquine or ...... x malaria in Papua New Guinea.
@nl
P2093
P921
P1476
Low efficacy of amodiaquine or ...... ax malaria in Papua New Guinea
@en
P2093
Albert Sie
Blaise Genton
Ivo Müeller
Jutta Marfurt
Mary Goroti
Peter Maku
P304
P356
10.4269/AJTMH.2007.77.947
P407
P577
2007-11-01T00:00:00Z